Google Übersetzer
Insight Molecular Diagnostics Inc.
About
6.09USD+0.21 +3.57%
Closed • Updated at 12:53 GMT+00:00Market Cap$196.65M
Volume371.2K
Beta1.29
RSI61.52
Gross Margin-64.88%
Insight Molecular Diagnostics Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 13 2026
IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization
May 6 2026
iMDx to Release First Quarter 2026 Results on May 13, 2026
Mar 26 2026
IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results
Mar 20 2026
iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference
Mar 13 2026
Second Study Affirms Superiority of iMDx GraftAssure Assay’s Proprietary dd-cfDNA Combination Model Score
Recent Videos
IMDX STOCK : POTENTIAL EXPANSION | INSIGHT MOLECULAR DIAGNOSTICS STOCK
May 05, 2026
IMDX: Insider just bought $2.0M | Apr 28, 2026 #Shorts
Apr 29, 2026
$IMDX — Last week, ten-percent owner Broadwood Partners went on a three-day shopping spree in…
Apr 28, 2026
Insight Molecular Diagnostics - The Decentralization Disruption
Apr 21, 2026
Community Chat
Ask AI
Try asking